Piper Sandler cuts BridgeBio Oncology Therapeutics target price to $15 from $21
BBOT•Piper Sandler cut its target price for BridgeBio Oncology Therapeutics to $15 from $21.
Related News
Continental stock divide erodes into a molehill
SPY•
Quanta Services expects 2026 technology and load centers revenue growth of 260%-280%
PWR•
Bond storm of 2026 may be passing, but Fed headwinds linger
TLT•
Asian FX slips as dollar firms on rate-hike bets, AI stocks extend recovery
TLT•
CIBC raises iA Financial target price to C$225 from C$220
IAG•